—A first-of-its-kind study demonstrated a significant genetic association between the KIT M541L variant and mastocytosis, particularly in indolent systemic mastocytosis. “Since data in mice have shown ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Cogent Biosciences, Inc. announced positive results from the SUMMIT clinical trial's Part 2, showing that the treatment bezuclastinib significantly improved total symptom scores in patients with ...
-- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an objective response rate (CR+CRh+PR+CI) of 57% per mIWG criteria and 80% per PPR criteria -- -- ...
In the complex world of rare diseases, even small advances in understanding can make a profound difference in patients’ lives. Medscape Live is bringing back-to-back educational programs to San Diego ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results